Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Price & Analysis

Compare

0 Followers

0874 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$15.76 - HK$24.00

Previous CloseN/A

Volume792.44K

Average Volume (3M)993.86K

Market Cap

$45.33B

Enterprise ValueN/A

Total Cash (Recent Filing)$14.51B

Total Debt (Recent Filing)¥11.55B

Price to Earnings (P/E)10.0

Beta0.67

Next Earnings

Aug 13, 2025

EPS EstimateN/A

Next Dividend Ex-Date

Jun 16, 2025

Dividend Yield7.36%

Share Statistics

EPS (TTM)1.22

Shares Outstanding219,900,000

10 Day Avg. Volume1,441,529

30 Day Avg. Volume993,864

Financial Highlights & Ratios

PEG Ratio-1.12

Price to Book (P/B)0.68

Price to Sales (P/S)0.00

P/FCF Ratio112.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$16.02

Price Target Upside-10.39% Downside

Rating ConsensusModerate Sell

Number of Analyst Covering0

Guangzhou Baiyunshan Pharmaceutical Holdings Company News

PremiumCompany Announcements

Guangzhou Baiyunshan Pharmaceutical Successfully Concludes 2024 AGM

4d ago

PremiumCompany Announcements

Guangzhou Baiyunshan Pharmaceutical Announces Board Composition and Roles

4d ago

PremiumCompany Announcements

Guangzhou Baiyunshan Announces Final Dividend for 2024

4d ago

PremiumCompany Announcements

Guangzhou Baiyunshan Pharmaceutical Announces Capital Increase for Subsidiary

10d ago

PremiumCompany Announcements

Guangzhou Baiyunshan’s GP Corp. Disposes Accounts Receivable in Disclosable Transaction

10d ago

PremiumCompany Announcements

Guangzhou Baiyunshan’s Subsidiary GP Corp. to Begin Trading on NEEQ

19d ago

PremiumCompany Announcements

Guangzhou Baiyunshan Reports Decrease in Q1 Profits

1M ago

PremiumCompany Announcements

Guangzhou Baiyunshan Reports Decline in Q1 2025 Earnings

1M ago

See All HK:0874 News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

3.69%

Mutual Funds

― Other Institutional Investors

92.92% Public Companies and

Individual Investors

Detailed Ownership Overview >

0874 FAQ

What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price range in the past 12 months?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H lowest stock price was HK$15.76 and its highest was HK$24.00 in the past 12 months.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap is $45.33B.

When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date is Aug 13, 2025 which is in 67 days.

How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s earnings last quarter?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H released its earnings results on Apr 30, 2025. The company reported HK$1.219 earnings per share for the quarter, beating the consensus estimate of HK$0.599 by HK$0.621.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H overvalued?

According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pay dividends?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pays a Annually dividend of HK$0.436 which represents an annual dividend yield of 7.36%. See more information on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividends here

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H have?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has 219,900,000 shares outstanding.

What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price movement after its last earnings report?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H reported an EPS of HK$1.219 in its last earnings report, beating expectations of HK$0.599. Following the earnings report the stock price went up 2.539%.

Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?

Currently, no hedge funds are holding shares in HK:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score

Underperform

Fundamentals

Return on Equity

7.22%

Trailing 12-Months

Asset Growth

1.37%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) is a leading pharmaceutical enterprise based in China, specializing in the research, development, production, and distribution of traditional Chinese medicines, chemical pharmaceuticals, and healthcare products. The company operates in several sectors including pharmaceuticals, healthcare, and consumer products, offering a diverse range of products aimed at improving health and wellness.

0874 Stock 12 Month Forecast

Average Price Target

HK$16.02

▼(-10.39%Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"HK$15","22":"HK$22","16.75":"HK$16.75","18.5":"HK$18.5","20.25":"HK$20.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16.0219017938,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$16.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.0219017938,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$16.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.0219017938,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$16.02</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,16.75,18.5,20.25,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2024","6":"Apr<br/>2024","9":"Jun<br/>2024","12":"Feb<br/>2025","25":"Feb<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.8,17.663223214907692,17.526446429815387,17.389669644723078,17.25289285963077,17.116116074538464,16.979339289446155,16.842562504353847,16.705785719261538,16.569008934169233,16.432232149076924,16.295455363984615,16.15867857889231,{"y":16.0219017938,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.8,17.663223214907692,17.526446429815387,17.389669644723078,17.25289285963077,17.116116074538464,16.979339289446155,16.842562504353847,16.705785719261538,16.569008934169233,16.432232149076924,16.295455363984615,16.15867857889231,{"y":16.0219017938,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.8,17.663223214907692,17.526446429815387,17.389669644723078,17.25289285963077,17.116116074538464,16.979339289446155,16.842562504353847,16.705785719261538,16.569008934169233,16.432232149076924,16.295455363984615,16.15867857889231,{"y":16.0219017938,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.211,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.8,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.365,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.835,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.173,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.941,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.154,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.659,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.929,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.929,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":17.887,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":18.32,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":17.8,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >